HeartCloud, Inc. is excited to announce the successful closing of a funding round, raising $350,000 to accelerate the next phase of our growth and innovation. This capital injection is a strong vote of confidence in our mission to empower physicians across the United States with cutting-edge software tools that facilitate better-informed treatment decisions using each patient’s digital health data. Our comprehensive, end-to-end platform not only provides robust clinical visualization but also streamlines revenue cycle management, ensuring that medical professionals can seamlessly integrate digital health modalities into their practice.
At the heart of our solution is a commitment to making patient care both efficient and effective. With support for a wide range of digital health modalities – from remote patient monitoring (RPM) and continuous glucose monitoring (CGM) to telehealth, movement disorder monitoring, principal care management, and chronic care management – HeartCloud is uniquely positioned to respond to the evolving needs of modern healthcare. Our platform is compatible with innovative devices such as FDA 510(k)-cleared blood pressure cuffs, weight and body composition scales with built-in 4G connectivity, and state-of-the-art continuous glucose monitors from Dexcom and FreeStyle Libre. Additionally, our iOS app, HeartCloud Sync, leverages data from devices like the Apple Watch and smart rings by Oura and Ultrahuman, while incorporating neurology-specific functionalities for comprehensive movement disorder monitoring.
The funds raised will be used to further refine our platform, expand our device integrations, and enhance our clinical and administrative tools. By doing so, we aim to not only support physicians in delivering top-notch patient care but also drive measurable improvements in healthcare outcomes. We look forward to this new chapter and are grateful for the support that fuels our continued commitment to transforming digital healthcare.
